TORONTO– Swift Medical, a digital health technology company focused on improving clinical and economic outcomes in wound care, has appointed Brian Litten as its new Chief Executive Officer effective immediately. The move signals the next chapter in Swift’s growth.
Litten brings decades of healthcare leadership experience across health plans, provider organizations, regulatory agencies, and technology solution providers, with a proven track record of transforming and growing health technology pioneers. Previously, Litten held various leadership positions in transformational, value-based healthcare companies, including Tabula Rasa HealthCare (clinical pharmacy), StationMD (emergency telehealth), Pearl Health (risk-based primary care), PathForward (medical oncology), and Blue Cross Blue Shield. His passionate outlook for access to quality care and diverse background positions him well as the company pushes for growth and continued enhancements to its wound care technology solutions.
“As advanced technologies deliver improved patient outcomes and cost savings in healthcare, one area ripe for innovation is wound care management – one of the most costly and overlooked threats to patients and health systems today,” said Michelle Scarborough, Managing Partner, BDC Capital and Swift Board Member. “Brian’s demonstrated ability to accelerate growth and drive operational excellence comes at a pivotal time, as Swift advances much-needed AI-driven, evidence-based solutions to create a new standard in wound care.”
Wounds are a growing public health issue presenting significant clinical, operational, and financial challenges. With over 8.2 million Medicare beneficiaries in the U.S. with wounds, 27-50% of hospital beds are occupied by patients requiring some form of wound management. Estimates for Medicare spending on wounds alone range up to $96 billion annually. The market is now projected to increase with a growing aging population and surging rates of obesity, diabetes, and surgeries.
“Delivering better outcomes in wound care is critical for the healthcare ecosystem and success of emerging value-based care models,” said Scott Guthrie, Chairman of the Board, Swift Medical; Partner, Virgo Investment Group. “We are confident Brian will ensure that Swift’s platform can meaningfully contribute to new outcomes-based plans, while meeting the essential and evolving needs of customers today and tomorrow.”
Swift Medical’s Skin and Wound technology is an AI-powered, digital wound platform utilized by over 4,000 healthcare organizations. It has been shown to deliver faster wound healing, better patient outcomes, reductions in re-hospitalization rates, hospital visits, supply costs, and wound assessment and documentation time.
Named to CB Insights’ Digital Health 150 annual ranking of the most promising digital health startups in the world for 2022, Swift is delivering innovative technology that allows clinicians to capture high-precision images of skin and wound conditions easily and accurately with a smartphone camera or tablet. The advanced technology determines wound clinical characteristics, tracks disease progression, and securely shares patient data in real-time for accurate reporting and tracking of individual patients and a health facility’s entire wound population.
“At the end of the day, it’s about the patient and improving access to high-quality care for those who need it most,” said Brian Litten, CEO of Swift Medical. “I look forward to working with the entire Swift team to deliver exceptional wound care through next generation technology that patients and providers have gone too long without.”
